Dr. Trapp is an Assistant Professor of Psychiatry at the University of Iowa, where he is the Director of the Interventional Psychiatry Program and the Neuropsychiatry Clinic. He completed medical school at the University of Nebraska, psychiatry residency at Washington University in St. Louis, followed by post-doctoral fellowship in neurostimulation and neuroimaging at the University of Iowa and behavioral neurology/neuropsychiatry fellowship at Stanford University. His research focuses on the targeting, application, and optimization of brain stimulation therapies for the treatment of neuropsychiatric conditions. Methods include TMS clinical trials, combining TMS and direct cortical stimulation with stereoencephalography, and lesion-network mapping of psychiatric symptoms to identify candidate brain stimulation targets. He led the National Network of Depression Centers Neuromodulation Task Group in the development of a new consensus document on the use of TMS for depression, and he serves on the Clinical TMS Society Research Committee. Clinically Dr. Trapp evaluates patients for TMS, ECT, DBS, VNS, and esketamine. He has received career development awards from the National Institutes of Mental Health, the American Neuropsychiatric Association, the American College of Neuropsychopharmacology, and the Brain and Behavior Research Foundation. His current research funding is to study the electrophysiologic effects of TMS in epilepsy patients with intracranial recording electrodes.